PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Induced pluripotent stem cell therapy ameliorates hyperoxia-augmented ventilator-induced lung injury through suppressing the Src pathway.

Mouse / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25310015 ↗2014Reported benefit

Induced pluripotent stem cell therapy ameliorates hyperoxia-augmented ventilator-induced lung injury through suppressing the Src pathway.

MouseOtherC57BL/6 wild type; Src-deficient heterozygotes on C57BL/6 background; iPSCs reprogrammed from mouse embryonic fibroblasts with Oct4, Sox2 and Parp1Malen = n=5 per group for most assays across six groups; n=3 per gr…Intravenous, tail vein5 x 10^7 cells/kgOne hour before mechanical ventilation

Model: Hyperoxia-augmented ventilator-induced lung injury using high tidal volume ventilation at 30 mL/kg with room air or hyperoxia for 1 to 4 h; non-ventilated mice as controls

Intravenous induced pluripotent stem cells given one hour before ventilation reduced Src phosphorylation, oxidative stress, neutrophil influx, MIP-2 and PAI-1, microvascular leak, oedema, epithelial apoptosis and lung injury score while improving oxygenation, mirroring protection in Src-deficient m…

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.